Flemming Hansen

996 total citations
16 papers, 378 citations indexed

About

Flemming Hansen is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Flemming Hansen has authored 16 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Flemming Hansen's work include Neutropenia and Cancer Infections (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Flemming Hansen is often cited by papers focused on Neutropenia and Cancer Infections (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Flemming Hansen collaborates with scholars based in Denmark, Sweden and India. Flemming Hansen's co-authors include Per Pfeiffer, Ole Færgeman, Torben F. Ørntoft, Mads H. Rasmussen, Line Schmidt Tarpgaard, Claus L. Andersen, Tine Plato Hansen, A. K. Pedersen, John Rasmussen and N. Gregersen and has published in prestigious journals such as Nature Communications, European Heart Journal and European Journal of Cancer.

In The Last Decade

Flemming Hansen

16 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Flemming Hansen Denmark	11	163	127	119	112	49	16	378
Lee Gorden United States	8	127 0.8×	154 1.2×	70 0.6×	205 1.8×	9 0.2×	11	407
Shinichi Asaka Japan	12	175 1.1×	96 0.8×	109 0.9×	161 1.4×	15 0.3×	58	462
Ahmed Awad United States	5	118 0.7×	78 0.6×	46 0.4×	50 0.4×	132 2.7×	8	355
Jong Ho Chun South Korea	10	130 0.8×	43 0.3×	114 1.0×	203 1.8×	17 0.3×	21	417
Angeles A. Alvarez United States	8	163 1.0×	90 0.7×	108 0.9×	136 1.2×	11 0.2×	11	405
Dominique Agbor‐Tarh Belgium	10	147 0.9×	129 1.0×	41 0.3×	362 3.2×	152 3.1×	22	516
F. Majois Belgium	9	56 0.3×	59 0.5×	29 0.2×	224 2.0×	55 1.1×	28	350
Emilio Burgos Spain	13	271 1.7×	107 0.8×	222 1.9×	95 0.8×	7 0.1×	23	602
Emma V. Morris United Kingdom	10	144 0.9×	120 0.9×	23 0.2×	133 1.2×	11 0.2×	14	374
Hiroyuki Maeta Japan	11	191 1.2×	96 0.8×	56 0.5×	146 1.3×	5 0.1×	24	419

Countries citing papers authored by Flemming Hansen

Since Specialization

Citations

This map shows the geographic impact of Flemming Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flemming Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flemming Hansen more than expected).

Fields of papers citing papers by Flemming Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flemming Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flemming Hansen. The network helps show where Flemming Hansen may publish in the future.

Co-authorship network of co-authors of Flemming Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Flemming Hansen. A scholar is included among the top collaborators of Flemming Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flemming Hansen. Flemming Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Sivesgaard, Kim, Lars Larsen, Michael Sørensen, et al.. (2017). Comparison of four MRI protocols for detection of extrahepatic colorectal cancer metastases. Journal of Magnetic Resonance Imaging. 46(6). 1619–1630. 2 indexed citations

Rasmussen, Mads H., Iben Lyskjær, Rosa Jersie-Christensen, et al.. (2016). miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells. Nature Communications. 7(1). 12436–12436. 70 indexed citations

Rasmussen, Mads H., Niels F. Jensen, Line Schmidt Tarpgaard, et al.. (2013). High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer. Molecular Oncology. 7(3). 637–646. 79 indexed citations

Vestermark, Lene Weber, Camilla Qvortrup, Flemming Hansen, et al.. (2008). Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Acta Oncologica. 47(3). 428–433. 20 indexed citations

Jess, Per, Lene Hjerrild Iversen, Mette Bak Nielsen, et al.. (2008). Quality of Life After Cytoreductive Surgery plus Early Intraperitoneal Postoperative Chemotherapy for Pseudomyxoma Peritonei: A Prospective Study. Diseases of the Colon & Rectum. 51(6). 868–874. 20 indexed citations

Gyldenkerne, Niels, Bengt Glimelius, Jan‐Erik Frödin, et al.. (2004). A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer. Acta Oncologica. 43(3). 276–279. 6 indexed citations

Jakobsen, Anders, Åke Berglund, Bengt Glimelius, et al.. (2002). Dose-effect Relationship of Bolus 5-Fluorouracil in the Treatment of Advanced Colorectal Cancer. Acta Oncologica. 41(6). 525–531. 23 indexed citations

Knudsen, Lene Meldgaard, Steen Werner Hansen, Lene Jarlbæk, et al.. (1998). Comparison of rhG–CSF primed bone marrow and blood stem cell autografts: an analysis of engraftment in malignant lymphomas and solid tumours. European Journal Of Haematology. 61(4). 229–234. 11 indexed citations

Hansen, Flemming, Lars Stenbygaard, & Torben Skovsgaard. (1995). Effect Of Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf) On Hematologic Toxicity Induced By High-Dose Chemotherapy In Patients With Metastatic Breast Cancer. Acta Oncologica. 34(7). 919–924. 8 indexed citations

10.

Hansen, Flemming. (1995). Hemopoietic Growth and Inhibitory Factors in Treatment of Malignancies: A review. Acta Oncologica. 34(4). 453–468. 11 indexed citations

11.

Daugaard, Gedske, Hans Jørgen Nielsen, Brita Bruun, et al.. (1993). Infections in patients treated with high-dose chemotherapy for germ cell tumours. European Journal of Cancer. 29(16). 2220–2222. 6 indexed citations

12.

Klausen, Ib Christian, Lars Ulrik Gerdes, Hans Meinertz, Flemming Hansen, & Ole Færgeman. (1993). Apolipoprotein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with familial hypercholesterolaemia treated with bile acid sequestration. European Journal of Clinical Investigation. 23(4). 240–245. 27 indexed citations

13.

Rüdiger, N., et al.. (1991). DNA deletions in the low density lipoprotein (LDL) receptor gene in Danish families with familial hypercholesterolemia. Clinical Genetics. 39(6). 451–462. 43 indexed citations

14.

Hansen, Flemming, et al.. (1990). Phase II clinical trial of VP-16-213 (etoposide) administered orally in advanced ovarian cancer. Gynecologic Oncology. 36(3). 369–370. 10 indexed citations

15.

Sihm, Inger, Flemming Hansen, John Rasmussen, A. K. Pedersen, & Kristian Thygesen. (1990). Flecainide acetate in atrial flutter and fibrillation. European Heart Journal. 11(2). 145–148. 33 indexed citations

16.

Lund, Birthe, Flemming Hansen, Mogens Hansen, & Heine H. Hansen. (1987). Phase II study of 1,2,4-triglycidylurazol (TGU) previously untreated and treated patients with small cell lung cancer. European Journal of Cancer and Clinical Oncology. 23(7). 1031–1033. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact